首页 > 最新文献

JMIR Cancer最新文献

英文 中文
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes. HER2定向曲妥珠单抗生物仿制药Ogivri与赫赛汀治疗乳腺癌的真实世界症状和健康状况报告登记数据比较:患者电子报告结果的前瞻性观察研究 (OGIPRO)》。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-04-04 DOI: 10.2196/54178
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu
<p><strong>Background: </strong>Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs).</p><p><strong>Objective: </strong>The primary objective of this prospective observational study (OGIPRO study) was to compare the ePRO data related to treatment side effects collected with the medidux app in patients with HER2-positive BC treated with the trastuzumab biosimilar Ogivri (prospective cohort) to those obtained from historical cohorts treated with Herceptin alone or combined with pertuzumab and/or chemotherapy (ClinicalTrials.gov NCT02004496 and NCT03578731).</p><p><strong>Methods: </strong>Patients were treated with Ogivri alone or combined with pertuzumab and/or chemotherapy and hormone therapy in (neo)adjuvant and palliative settings. Patients used the medidux app to dynamically record symptoms (according to the Common Terminology Criteria for Adverse Events [CTCAE]), well-being (according to the Eastern Cooperative Oncology Group Performance Status scale), QoL (using the EQ-5D-5L questionnaire), cognitive capabilities, and vital parameters over 6 weeks. The primary endpoint was the mean CTCAE score. Key secondary endpoints included the mean well-being score. Data of this prospective cohort were compared with those of the historical cohorts (n=38 patients; median age 51, range 31-78 years).</p><p><strong>Results: </strong>Overall, 53 female patients with a median age of 54 years (range 31-87 years) were enrolled in the OGIPRO study. The mean CTCAE score was analyzed in 50 patients with available data on symptoms, while the mean well-being score was evaluated in 52 patients with available data. The most common symptoms reported in both cohorts included fatigue, taste disorder, nausea, diarrhea, dry mucosa, joint discomfort, tingling, sleep disorder, headache, and appetite loss. Most patients experienced minimal (grade 0) or mild (grade 1) toxicities in both cohorts. The mean CTCAE score was comparable between the prospective and historical cohorts (29.0 and 30.3, respectively; mean difference -1.27, 95% CI -7.24 to 4.70; P=.68). Similarly, no significant difference was found for the mean well-being score between the groups treated with the trastuzumab biosimilar Ogivri and Herceptin (74.3 and 69.8, respectively; mean difference 4.45, 95% CI -3.53 to 12.44; P=.28).</p><p><strong>Conclusions: </strong>Treatment of patients with HER2-positive BC with the trastuzumab biosimilar Ogivri resulted in equivalent symptoms, adverse events, and well-being as found for patients treated with Herceptin as determined by ePRO data. Hence, in
背景:曲妥珠单抗对人类表皮生长因子受体 2(HER2)阳性乳腺癌(BC)的治疗产生了重大影响。在临床试验中,抗 HER2 生物仿制药(如 Ogivri)已证明与曲妥珠单抗(以赫赛汀为参照产品)具有安全性和临床等效性。据我们所知,目前还没有使用电子患者报告结果(ePROs)对接受生物仿制药治疗的患者的副作用和生活质量(QoL)进行真实世界报告:这项前瞻性观察研究(OGIPRO 研究)的主要目的是比较使用 medidux 应用程序收集的 HER2 阳性 BC 患者在接受曲妥珠单抗生物仿制药 Ogivri(前瞻性队列)治疗后的治疗副作用相关 ePRO 数据,以及从单独使用赫赛汀或联合百妥珠单抗和/或化疗的历史队列(ClinicalTrials.gov NCT02004496 和 NCT03578731)中获得的数据:在(新)辅助治疗和姑息治疗中,患者接受Ogivri单药或联合百妥珠单抗和/或化疗及激素治疗。患者使用 medidux 应用程序在 6 周内动态记录症状(根据不良事件通用术语标准 [CTCAE])、健康状况(根据东部合作肿瘤学组表现状态量表)、QoL(使用 EQ-5D-5L 问卷)、认知能力和生命参数。主要终点是 CTCAE 平均得分。主要次要终点包括平均健康评分。该前瞻性队列的数据与历史队列的数据进行了比较(38 名患者,中位年龄 51 岁,31-78 岁):共有 53 名女性患者参加了 OGIPRO 研究,中位年龄为 54 岁(31-87 岁不等)。对 50 名有症状数据的患者的平均 CTCAE 评分进行了分析,对 52 名有症状数据的患者的平均健康评分进行了评估。两组患者中最常见的症状包括疲劳、味觉障碍、恶心、腹泻、粘膜干燥、关节不适、刺痛、睡眠障碍、头痛和食欲不振。在两组患者中,大多数患者的毒性极小(0 级)或轻微(1 级)。前瞻性队列和历史性队列的平均 CTCAE 评分相当(分别为 29.0 分和 30.3 分;平均差异-1.27,95% CI -7.24 至 4.70;P=.68)。同样,使用曲妥珠单抗生物仿制药Ogivri和赫赛汀治疗的组别之间的平均幸福感得分也没有明显差异(分别为74.3和69.8;平均差异为4.45,95% CI为-3.53至12.44;P=.28):根据 ePRO 数据,使用曲妥珠单抗生物仿制药 Ogivri 治疗 HER2 阳性 BC 患者的症状、不良事件和健康状况与使用赫赛汀治疗的患者相当。因此,在研究类似治疗化合物的实际耐受性和结果时,将 ePRO 系统纳入研究和临床实践可提供可靠的信息:试验注册:ClinicalTrials.gov NCT05234021;https://clinicaltrials.gov/study/NCT05234021。
{"title":"Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.","authors":"Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu","doi":"10.2196/54178","DOIUrl":"https://doi.org/10.2196/54178","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Trastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using Herceptin as the reference product) in clinical trials. To our knowledge, there has been no real-world report of the side effects and quality of life (QoL) in patients treated with biosimilars using electronic patient-reported outcomes (ePROs).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The primary objective of this prospective observational study (OGIPRO study) was to compare the ePRO data related to treatment side effects collected with the medidux app in patients with HER2-positive BC treated with the trastuzumab biosimilar Ogivri (prospective cohort) to those obtained from historical cohorts treated with Herceptin alone or combined with pertuzumab and/or chemotherapy (ClinicalTrials.gov NCT02004496 and NCT03578731).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients were treated with Ogivri alone or combined with pertuzumab and/or chemotherapy and hormone therapy in (neo)adjuvant and palliative settings. Patients used the medidux app to dynamically record symptoms (according to the Common Terminology Criteria for Adverse Events [CTCAE]), well-being (according to the Eastern Cooperative Oncology Group Performance Status scale), QoL (using the EQ-5D-5L questionnaire), cognitive capabilities, and vital parameters over 6 weeks. The primary endpoint was the mean CTCAE score. Key secondary endpoints included the mean well-being score. Data of this prospective cohort were compared with those of the historical cohorts (n=38 patients; median age 51, range 31-78 years).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Overall, 53 female patients with a median age of 54 years (range 31-87 years) were enrolled in the OGIPRO study. The mean CTCAE score was analyzed in 50 patients with available data on symptoms, while the mean well-being score was evaluated in 52 patients with available data. The most common symptoms reported in both cohorts included fatigue, taste disorder, nausea, diarrhea, dry mucosa, joint discomfort, tingling, sleep disorder, headache, and appetite loss. Most patients experienced minimal (grade 0) or mild (grade 1) toxicities in both cohorts. The mean CTCAE score was comparable between the prospective and historical cohorts (29.0 and 30.3, respectively; mean difference -1.27, 95% CI -7.24 to 4.70; P=.68). Similarly, no significant difference was found for the mean well-being score between the groups treated with the trastuzumab biosimilar Ogivri and Herceptin (74.3 and 69.8, respectively; mean difference 4.45, 95% CI -3.53 to 12.44; P=.28).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Treatment of patients with HER2-positive BC with the trastuzumab biosimilar Ogivri resulted in equivalent symptoms, adverse events, and well-being as found for patients treated with Herceptin as determined by ePRO data. Hence, in","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e54178"},"PeriodicalIF":2.8,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach. 共同设计、开发和评估用于改善癌症患者用药依从性的移动解决方案:设计科学研究方法。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-04-03 DOI: 10.2196/46979
Thu Ha Dang, Nilmini Wickramasinghe, Abdur Rahim Mohammad Forkan, Prem Prakash Jayaraman, Kate Burbury, Clare O'Callaghan, Ashley Whitechurch, Penelope Schofield

Background: Medication nonadherence negatively impacts the health outcomes of people with cancer as well as health care costs. Digital technologies present opportunities to address this health issue. However, there is limited evidence on how to develop digital interventions that meet the needs of people with cancer, are perceived as useful, and are potentially effective in improving medication adherence.

Objective: The objective of this study was to co-design, develop, and preliminarily evaluate an innovative mobile health solution called Safety and Adherence to Medication and Self-Care Advice in Oncology (SAMSON) to improve medication adherence among people with cancer.

Methods: Using the 4 cycles and 6 processes of design science research methodology, we co-designed and developed a medication adherence solution for people with cancer. First, we conducted a literature review on medication adherence in cancer and a systematic review of current interventions to address this issue. Behavioral science research was used to conceptualize the design features of SAMSON. Second, we conducted 2 design phases: prototype design and final feature design. Last, we conducted a mixed methods study on patients with hematological cancer over 6 weeks to evaluate the mobile solution.

Results: The developed mobile solution, consisting of a mobile app, a web portal, and a cloud-based database, includes 5 modules: medication reminder and acknowledgment, symptom assessment and management, reinforcement, patient profile, and reporting. The quantitative study (n=30) showed that SAMSON was easy to use (21/27, 78%). The app was engaging (18/27, 67%), informative, increased user interactions, and well organized (19/27, 70%). Most of the participants (21/27, 78%) commented that SAMSON's activities could help to improve their adherence to cancer treatments, and more than half of them (17/27, 63%) would recommend the app to their peers. The qualitative study (n=25) revealed that SAMSON was perceived as helpful in terms of reminding, supporting, and informing patients. Possible barriers to using SAMSON include the app glitches and users' technical inexperience. Further needs to refine the solution were also identified. Technical improvements and design enhancements will be incorporated into the subsequent iteration.

Conclusions: This study demonstrates the successful application of behavioral science research and design science research methodology to design and develop a mobile solution for patients with cancer to be more adherent. The study also highlights the importance of applying rigorous methodologies in developing effective and patient-centered digital intervention solutions.

背景:不遵医嘱用药会对癌症患者的健康状况和医疗成本产生负面影响。数字技术为解决这一健康问题提供了机会。然而,关于如何开发符合癌症患者需求、被认为有用并能有效改善用药依从性的数字干预措施,目前证据还很有限:本研究的目的是共同设计、开发并初步评估一种名为 "肿瘤用药安全与依从性及自我护理建议"(SAMSON)的创新型移动医疗解决方案,以改善癌症患者的用药依从性:利用设计科学研究方法的 4 个周期和 6 个过程,我们共同设计并开发了针对癌症患者的用药依从性解决方案。首先,我们对癌症患者的服药依从性进行了文献综述,并对当前解决这一问题的干预措施进行了系统性综述。行为科学研究被用于构思 SAMSON 的设计特点。其次,我们进行了两个设计阶段:原型设计和最终功能设计。最后,我们对血液肿瘤患者进行了为期6周的混合方法研究,以评估移动解决方案:开发的移动解决方案由移动应用程序、门户网站和云数据库组成,包括 5 个模块:用药提醒和确认、症状评估和管理、强化、患者档案和报告。定量研究(n=30)显示,SAMSON 易于使用(21/27,78%)。该应用程序引人入胜(18/27,67%),信息量大,增加了用户互动,组织良好(19/27,70%)。大多数参与者(21/27,78%)表示,SAMSON 的活动有助于提高他们对癌症治疗的依从性,超过半数的参与者(17/27,63%)会向同伴推荐该应用程序。定性研究(n=25)显示,SAMSON 在提醒、支持和告知患者方面很有帮助。使用 SAMSON 可能遇到的障碍包括应用程序故障和用户缺乏技术经验。此外,还发现了进一步完善解决方案的需求。技术改进和设计提升将纳入后续迭代中:本研究表明,行为科学研究和设计科学研究方法成功地应用于设计和开发移动解决方案,使癌症患者更加坚持治疗。该研究还强调了在开发有效的、以患者为中心的数字干预解决方案时应用严格方法的重要性。
{"title":"Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach.","authors":"Thu Ha Dang, Nilmini Wickramasinghe, Abdur Rahim Mohammad Forkan, Prem Prakash Jayaraman, Kate Burbury, Clare O'Callaghan, Ashley Whitechurch, Penelope Schofield","doi":"10.2196/46979","DOIUrl":"https://doi.org/10.2196/46979","url":null,"abstract":"<p><strong>Background: </strong>Medication nonadherence negatively impacts the health outcomes of people with cancer as well as health care costs. Digital technologies present opportunities to address this health issue. However, there is limited evidence on how to develop digital interventions that meet the needs of people with cancer, are perceived as useful, and are potentially effective in improving medication adherence.</p><p><strong>Objective: </strong>The objective of this study was to co-design, develop, and preliminarily evaluate an innovative mobile health solution called Safety and Adherence to Medication and Self-Care Advice in Oncology (SAMSON) to improve medication adherence among people with cancer.</p><p><strong>Methods: </strong>Using the 4 cycles and 6 processes of design science research methodology, we co-designed and developed a medication adherence solution for people with cancer. First, we conducted a literature review on medication adherence in cancer and a systematic review of current interventions to address this issue. Behavioral science research was used to conceptualize the design features of SAMSON. Second, we conducted 2 design phases: prototype design and final feature design. Last, we conducted a mixed methods study on patients with hematological cancer over 6 weeks to evaluate the mobile solution.</p><p><strong>Results: </strong>The developed mobile solution, consisting of a mobile app, a web portal, and a cloud-based database, includes 5 modules: medication reminder and acknowledgment, symptom assessment and management, reinforcement, patient profile, and reporting. The quantitative study (n=30) showed that SAMSON was easy to use (21/27, 78%). The app was engaging (18/27, 67%), informative, increased user interactions, and well organized (19/27, 70%). Most of the participants (21/27, 78%) commented that SAMSON's activities could help to improve their adherence to cancer treatments, and more than half of them (17/27, 63%) would recommend the app to their peers. The qualitative study (n=25) revealed that SAMSON was perceived as helpful in terms of reminding, supporting, and informing patients. Possible barriers to using SAMSON include the app glitches and users' technical inexperience. Further needs to refine the solution were also identified. Technical improvements and design enhancements will be incorporated into the subsequent iteration.</p><p><strong>Conclusions: </strong>This study demonstrates the successful application of behavioral science research and design science research methodology to design and develop a mobile solution for patients with cancer to be more adherent. The study also highlights the importance of applying rigorous methodologies in developing effective and patient-centered digital intervention solutions.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e46979"},"PeriodicalIF":2.8,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Web-Based Information and Resources That Support Adolescents and Young Adults With Cancer to Resume Study and Work: Environmental Scan Study. 探索支持青少年癌症患者恢复学习和工作的网络信息和资源:环境扫描研究。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-03-25 DOI: 10.2196/47944
Clarissa E Schilstra, Sarah J Ellis, Jennifer Cohen, Alana Gall, Abbey Diaz, Kristina Clarke, Gadiel Dumlao, Jennifer Chard, Therese M Cumming, Esther Davis, Haryana Dhillon, Mary Anne Burns, Kimberley Docking, Eng-Siew Koh, Josephine O'Reilly, Ursula M Sansom-Daly, Joanne Shaw, Nicole Speers, Natalie Taylor, Anthea Warne, Joanna E Fardell

Background: Adolescents and young adults (AYAs) diagnosed with cancer experience physical, cognitive, and psychosocial effects from cancer treatment that can negatively affect their ability to remain engaged in education or work through cancer treatment and in the long term. Disengagement from education or work can have lasting implications for AYAs' financial independence, psychosocial well-being, and quality of life. Australian AYAs with cancer lack access to adequate specialist support for their education and work needs and report a preference for web-based support that they can access from anywhere, in their own time. However, it remains unclear what web-based resources exist that are tailored to support AYAs with cancer in reaching their educational or work goals.

Objective: This study aimed to determine what web-based resources exist for Australian AYAs with cancer to (1) support return to education or work and (2) identify the degree to which existing resources are age-specific, cancer-specific, culturally inclusive, and evidence-based; are co-designed with AYAs; use age-appropriate language; and are easy to find.

Methods: We conducted an environmental scan by searching Google with English search terms in August 2022 to identify information resources about employment and education for AYAs ever diagnosed with cancer. Data extraction was conducted in Microsoft Excel, and the following were assessed: understandability and actionability (using the Patient Education and Materials Tool), readability (using the Sydney Health Literacy Laboratory Health Literacy Editor), and whether the resource was easy to locate, evidence-based, co-designed with AYAs, and culturally inclusive of Aboriginal and Torres Strait Islander peoples. The latter was assessed using 7 criteria previously developed by members of the research team.

Results: We identified 24 web-based resources, comprising 22 written text resources and 12 video resources. Most resources (21/24, 88%) were published by nongovernmental organizations in Australia, Canada, the United States, and the United Kingdom. A total of 7 resources focused on education, 8 focused on work, and 9 focused on both education and work. The evaluation of resources demonstrated poor understandability and actionability. Resources were rarely evidence-based or co-designed by AYAs, difficult to locate on the internet, and largely not inclusive of Aboriginal and Torres Strait Islander populations.

Conclusions: Although web-based resources for AYAs with cancer are often available through the websites of hospitals or nongovernmental organizations, this environmental scan suggests they would benefit from more evidence-based and actionable resources that are available in multiple formats (eg, text and audio-visual) and tailored to be age-appropriate and culturally inclusive.

背景:被诊断出患有癌症的青少年和年轻成人(AYAs)会因癌症治疗而受到身体、认知和社会心理方面的影响,这可能会对他们在癌症治疗期间和长期继续接受教育或工作的能力产生负面影响。脱离教育或工作会对青少年的经济独立、社会心理健康和生活质量产生持久影响。患有癌症的澳大利亚青少年无法获得足够的专家支持来满足他们的教育和工作需求,他们表示更喜欢可以随时随地、利用自己的时间获得的网络支持。然而,目前尚不清楚有哪些网络资源是专门为帮助患有癌症的澳大利亚青年患者实现其教育或工作目标而量身定制的:本研究旨在确定有哪些网络资源可供患有癌症的澳大利亚青少年使用,以(1)支持他们重返校园或工作岗位;(2)确定现有资源在多大程度上具有年龄针对性、癌症针对性、文化包容性和循证性;是否与青少年共同设计;是否使用适合青少年的语言;以及是否易于查找:我们于 2022 年 8 月在谷歌上使用英文搜索词进行了一次环境扫描,以确定曾被诊断出患有癌症的亚裔美国人的就业和教育信息资源。数据提取在 Microsoft Excel 中进行,并对以下方面进行了评估:可理解性和可操作性(使用 "患者教育和材料工具")、可读性(使用 "悉尼健康扫盲实验室健康扫盲编辑器"),以及资源是否易于查找、是否以证据为基础、是否与青壮年共同设计、是否在文化上包容土著居民和托雷斯海峡岛民。后者采用研究小组成员之前制定的 7 项标准进行评估:我们确定了 24 种网络资源,包括 22 种文字资源和 12 种视频资源。大多数资源(21/24,88%)由澳大利亚、加拿大、美国和英国的非政府组织出版。共有 7 个资源侧重于教育,8 个侧重于工作,9 个同时侧重于教育和工作。对资源的评估表明,其可理解性和可操作性都很差。这些资源很少以证据为基础,也很少由青少年共同设计,很难在互联网上找到,而且大多不包括土著居民和托雷斯海峡岛民:尽管针对罹患癌症的青少年的网络资源通常可通过医院或非政府组织的网站获得,但此次环境扫描表明,以多种形式(如文本和视听)提供更多循证和可操作的资源,并根据年龄和文化包容性进行定制,将使他们受益匪浅。
{"title":"Exploring Web-Based Information and Resources That Support Adolescents and Young Adults With Cancer to Resume Study and Work: Environmental Scan Study.","authors":"Clarissa E Schilstra, Sarah J Ellis, Jennifer Cohen, Alana Gall, Abbey Diaz, Kristina Clarke, Gadiel Dumlao, Jennifer Chard, Therese M Cumming, Esther Davis, Haryana Dhillon, Mary Anne Burns, Kimberley Docking, Eng-Siew Koh, Josephine O'Reilly, Ursula M Sansom-Daly, Joanne Shaw, Nicole Speers, Natalie Taylor, Anthea Warne, Joanna E Fardell","doi":"10.2196/47944","DOIUrl":"10.2196/47944","url":null,"abstract":"<p><strong>Background: </strong>Adolescents and young adults (AYAs) diagnosed with cancer experience physical, cognitive, and psychosocial effects from cancer treatment that can negatively affect their ability to remain engaged in education or work through cancer treatment and in the long term. Disengagement from education or work can have lasting implications for AYAs' financial independence, psychosocial well-being, and quality of life. Australian AYAs with cancer lack access to adequate specialist support for their education and work needs and report a preference for web-based support that they can access from anywhere, in their own time. However, it remains unclear what web-based resources exist that are tailored to support AYAs with cancer in reaching their educational or work goals.</p><p><strong>Objective: </strong>This study aimed to determine what web-based resources exist for Australian AYAs with cancer to (1) support return to education or work and (2) identify the degree to which existing resources are age-specific, cancer-specific, culturally inclusive, and evidence-based; are co-designed with AYAs; use age-appropriate language; and are easy to find.</p><p><strong>Methods: </strong>We conducted an environmental scan by searching Google with English search terms in August 2022 to identify information resources about employment and education for AYAs ever diagnosed with cancer. Data extraction was conducted in Microsoft Excel, and the following were assessed: understandability and actionability (using the Patient Education and Materials Tool), readability (using the Sydney Health Literacy Laboratory Health Literacy Editor), and whether the resource was easy to locate, evidence-based, co-designed with AYAs, and culturally inclusive of Aboriginal and Torres Strait Islander peoples. The latter was assessed using 7 criteria previously developed by members of the research team.</p><p><strong>Results: </strong>We identified 24 web-based resources, comprising 22 written text resources and 12 video resources. Most resources (21/24, 88%) were published by nongovernmental organizations in Australia, Canada, the United States, and the United Kingdom. A total of 7 resources focused on education, 8 focused on work, and 9 focused on both education and work. The evaluation of resources demonstrated poor understandability and actionability. Resources were rarely evidence-based or co-designed by AYAs, difficult to locate on the internet, and largely not inclusive of Aboriginal and Torres Strait Islander populations.</p><p><strong>Conclusions: </strong>Although web-based resources for AYAs with cancer are often available through the websites of hospitals or nongovernmental organizations, this environmental scan suggests they would benefit from more evidence-based and actionable resources that are available in multiple formats (eg, text and audio-visual) and tailored to be age-appropriate and culturally inclusive.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e47944"},"PeriodicalIF":2.8,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11002739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140207869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning Approaches to Predict Symptoms in People With Cancer: Systematic Review. 预测癌症患者症状的机器学习方法:系统综述。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-03-19 DOI: 10.2196/52322
Nahid Zeinali, Nayung Youn, Alaa Albashayreh, Weiguo Fan, Stéphanie Gilbertson White
<p><strong>Background: </strong>People with cancer frequently experience severe and distressing symptoms associated with cancer and its treatments. Predicting symptoms in patients with cancer continues to be a significant challenge for both clinicians and researchers. The rapid evolution of machine learning (ML) highlights the need for a current systematic review to improve cancer symptom prediction.</p><p><strong>Objective: </strong>This systematic review aims to synthesize the literature that has used ML algorithms to predict the development of cancer symptoms and to identify the predictors of these symptoms. This is essential for integrating new developments and identifying gaps in existing literature.</p><p><strong>Methods: </strong>We conducted this systematic review in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist. We conducted a systematic search of CINAHL, Embase, and PubMed for English records published from 1984 to August 11, 2023, using the following search terms: cancer, neoplasm, specific symptoms, neural networks, machine learning, specific algorithm names, and deep learning. All records that met the eligibility criteria were individually reviewed by 2 coauthors, and key findings were extracted and synthesized. We focused on studies using ML algorithms to predict cancer symptoms, excluding nonhuman research, technical reports, reviews, book chapters, conference proceedings, and inaccessible full texts.</p><p><strong>Results: </strong>A total of 42 studies were included, the majority of which were published after 2017. Most studies were conducted in North America (18/42, 43%) and Asia (16/42, 38%). The sample sizes in most studies (27/42, 64%) typically ranged from 100 to 1000 participants. The most prevalent category of algorithms was supervised ML, accounting for 39 (93%) of the 42 studies. Each of the methods-deep learning, ensemble classifiers, and unsupervised ML-constituted 3 (3%) of the 42 studies. The ML algorithms with the best performance were logistic regression (9/42, 17%), random forest (7/42, 13%), artificial neural networks (5/42, 9%), and decision trees (5/42, 9%). The most commonly included primary cancer sites were the head and neck (9/42, 22%) and breast (8/42, 19%), with 17 (41%) of the 42 studies not specifying the site. The most frequently studied symptoms were xerostomia (9/42, 14%), depression (8/42, 13%), pain (8/42, 13%), and fatigue (6/42, 10%). The significant predictors were age, gender, treatment type, treatment number, cancer site, cancer stage, chemotherapy, radiotherapy, chronic diseases, comorbidities, physical factors, and psychological factors.</p><p><strong>Conclusions: </strong>This review outlines the algorithms used for predicting symptoms in individuals with cancer. Given the diversity of symptoms people with cancer experience, analytic approaches that can handle complex and nonlinear relationships are critical. This knowledge can pav
背景:癌症患者经常会出现与癌症及其治疗相关的严重而痛苦的症状。预测癌症患者的症状仍然是临床医生和研究人员面临的一项重大挑战。机器学习(ML)的快速发展凸显了当前系统综述改善癌症症状预测的必要性:本系统综述旨在综合使用 ML 算法预测癌症症状发展的文献,并确定这些症状的预测因素。这对于整合新的发展和确定现有文献中的空白点至关重要:我们按照 PRISMA(系统综述和元分析首选报告项目)清单进行了此次系统综述。我们在CINAHL、Embase和PubMed上对1984年至2023年8月11日发表的英文记录进行了系统检索,检索词包括:癌症、肿瘤、特定症状、神经网络、机器学习、特定算法名称和深度学习。所有符合资格标准的记录都由两位共同作者进行了逐一审阅,并提取和归纳了主要发现。我们重点关注使用 ML 算法预测癌症症状的研究,排除了非人类研究、技术报告、综述、书籍章节、会议论文集以及无法访问的全文:共纳入42项研究,其中大部分研究发表于2017年之后。大多数研究在北美(18/42,43%)和亚洲(16/42,38%)进行。大多数研究(27/42,64%)的样本量通常在 100 到 1000 名参与者之间。最普遍的算法类别是有监督的 ML,占 42 项研究中的 39 项(93%)。在 42 项研究中,深度学习、集合分类器和无监督 ML 各占 3 项(3%)。性能最好的 ML 算法是逻辑回归(9/42,17%)、随机森林(7/42,13%)、人工神经网络(5/42,9%)和决策树(5/42,9%)。最常见的原发癌症部位是头颈部(9/42,22%)和乳腺(8/42,19%),42 项研究中有 17 项(41%)未说明具体部位。研究中最常见的症状是口腔干燥(9/42,14%)、抑郁(8/42,13%)、疼痛(8/42,13%)和疲劳(6/42,10%)。重要的预测因素包括年龄、性别、治疗类型、治疗次数、癌症部位、癌症分期、化疗、放疗、慢性病、合并症、身体因素和心理因素:本综述概述了用于预测癌症患者症状的算法。鉴于癌症患者的症状多种多样,能够处理复杂和非线性关系的分析方法至关重要。这方面的知识可以为制定针对特定症状的算法铺平道路。此外,为了提高预测精度,未来的研究应将深度学习和集合方法等前沿的 ML 策略与传统的统计模型进行比较。
{"title":"Machine Learning Approaches to Predict Symptoms in People With Cancer: Systematic Review.","authors":"Nahid Zeinali, Nayung Youn, Alaa Albashayreh, Weiguo Fan, Stéphanie Gilbertson White","doi":"10.2196/52322","DOIUrl":"10.2196/52322","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;People with cancer frequently experience severe and distressing symptoms associated with cancer and its treatments. Predicting symptoms in patients with cancer continues to be a significant challenge for both clinicians and researchers. The rapid evolution of machine learning (ML) highlights the need for a current systematic review to improve cancer symptom prediction.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This systematic review aims to synthesize the literature that has used ML algorithms to predict the development of cancer symptoms and to identify the predictors of these symptoms. This is essential for integrating new developments and identifying gaps in existing literature.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We conducted this systematic review in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist. We conducted a systematic search of CINAHL, Embase, and PubMed for English records published from 1984 to August 11, 2023, using the following search terms: cancer, neoplasm, specific symptoms, neural networks, machine learning, specific algorithm names, and deep learning. All records that met the eligibility criteria were individually reviewed by 2 coauthors, and key findings were extracted and synthesized. We focused on studies using ML algorithms to predict cancer symptoms, excluding nonhuman research, technical reports, reviews, book chapters, conference proceedings, and inaccessible full texts.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 42 studies were included, the majority of which were published after 2017. Most studies were conducted in North America (18/42, 43%) and Asia (16/42, 38%). The sample sizes in most studies (27/42, 64%) typically ranged from 100 to 1000 participants. The most prevalent category of algorithms was supervised ML, accounting for 39 (93%) of the 42 studies. Each of the methods-deep learning, ensemble classifiers, and unsupervised ML-constituted 3 (3%) of the 42 studies. The ML algorithms with the best performance were logistic regression (9/42, 17%), random forest (7/42, 13%), artificial neural networks (5/42, 9%), and decision trees (5/42, 9%). The most commonly included primary cancer sites were the head and neck (9/42, 22%) and breast (8/42, 19%), with 17 (41%) of the 42 studies not specifying the site. The most frequently studied symptoms were xerostomia (9/42, 14%), depression (8/42, 13%), pain (8/42, 13%), and fatigue (6/42, 10%). The significant predictors were age, gender, treatment type, treatment number, cancer site, cancer stage, chemotherapy, radiotherapy, chronic diseases, comorbidities, physical factors, and psychological factors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This review outlines the algorithms used for predicting symptoms in individuals with cancer. Given the diversity of symptoms people with cancer experience, analytic approaches that can handle complex and nonlinear relationships are critical. This knowledge can pav","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52322"},"PeriodicalIF":2.8,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Need for Culturally Competent and Responsive Cancer Education for African Immigrant Families and Youth Living in the United States. 需要为生活在美国的非洲移民家庭和青少年提供符合其文化背景并具有针对性的癌症教育。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-03-06 DOI: 10.2196/53956
Olufunmilola Abraham, Adeola Agoke, Kazeem Sanuth, Abimbola Fapohunda, Motolani Ogunsanya, Megan Piper, Amy Trentham-Dietz

Cancer prevalence data for Black Americans is monolithic and fails to consider the diverse cultures and backgrounds within that community. For instance, African immigrants constitute a meaningful proportion of the foreign-born Black immigrants in the United States (42%), but the prevalence of cancer in the African immigrant community itself is unknown. Therefore, without accurate cancer prevalence data, it is impossible to identify trends and other key factors that are needed to support the health of African immigrants and their children. Moreover, it is impossible to understand how the culture and language of subgroups influence their cancer-related health behavior. While research in this area is limited, the existing literature articulates the need for culturally responsive and culturally tailored cancer education for African immigrants and their adolescent children, which is what we advocate for in this viewpoint paper. Existing projects demonstrate the feasibility of culturally responsive programming for adults; however, few projects include or focus on adolescents or children born to African immigrants. To best meet the needs of this understudied community, researchers must use culturally competent interventions alongside familiar, usable media. For adolescents, technology is ubiquitous thus, the creation of a culturally tailored digital intervention has immense potential to improve cancer awareness and prevention for youth and their community. More research is needed to address many of the existing research gaps and develop a rich understanding of the unique experience of cancer among African immigrant families that can be used to inform intervention development. Through this viewpoint, we review the current state of cancer-related research among African immigrant families in the United States. In this paper, we acknowledge the current knowledge gaps and issues surrounding measurement and then discuss the factors relevant to designing an educational intervention targeted at African immigrants and the role of African immigrant youth.

美国黑人的癌症发病率数据是单一的,没有考虑到该社区内的不同文化和背景。例如,非洲移民在美国外国出生的黑人移民中占有相当大的比例(42%),但非洲移民社区本身的癌症发病率却不得而知。因此,如果没有准确的癌症发病率数据,就无法确定非洲移民及其子女健康所需的趋势和其他关键因素。此外,也无法了解亚群体的文化和语言如何影响他们与癌症有关的健康行为。虽然该领域的研究有限,但现有文献阐明了针对非洲移民及其青少年子女开展文化响应和文化定制癌症教育的必要性,这也是我们在本观点文件中所倡导的。现有的项目表明,针对成年人的文化敏感性计划是可行的;然而,很少有项目包括或关注青少年或非洲移民的子女。为了最大限度地满足这一未被充分研究的群体的需求,研究人员必须在使用熟悉的、可用的媒体的同时,使用具有文化适应性的干预措施。对于青少年来说,技术无处不在,因此,创造一种符合其文化背景的数字干预措施,对于提高青少年及其社区对癌症的认识和预防具有巨大的潜力。我们需要开展更多的研究,以弥补现有的许多研究空白,并对非洲移民家庭患癌的独特经历形成丰富的认识,从而为干预措施的开发提供依据。通过这一观点,我们回顾了美国非洲裔移民家庭癌症相关研究的现状。在本文中,我们承认目前的知识差距和围绕测量的问题,然后讨论与设计针对非洲移民的教育干预措施相关的因素以及非洲移民青年的作用。
{"title":"Need for Culturally Competent and Responsive Cancer Education for African Immigrant Families and Youth Living in the United States.","authors":"Olufunmilola Abraham, Adeola Agoke, Kazeem Sanuth, Abimbola Fapohunda, Motolani Ogunsanya, Megan Piper, Amy Trentham-Dietz","doi":"10.2196/53956","DOIUrl":"10.2196/53956","url":null,"abstract":"<p><p>Cancer prevalence data for Black Americans is monolithic and fails to consider the diverse cultures and backgrounds within that community. For instance, African immigrants constitute a meaningful proportion of the foreign-born Black immigrants in the United States (42%), but the prevalence of cancer in the African immigrant community itself is unknown. Therefore, without accurate cancer prevalence data, it is impossible to identify trends and other key factors that are needed to support the health of African immigrants and their children. Moreover, it is impossible to understand how the culture and language of subgroups influence their cancer-related health behavior. While research in this area is limited, the existing literature articulates the need for culturally responsive and culturally tailored cancer education for African immigrants and their adolescent children, which is what we advocate for in this viewpoint paper. Existing projects demonstrate the feasibility of culturally responsive programming for adults; however, few projects include or focus on adolescents or children born to African immigrants. To best meet the needs of this understudied community, researchers must use culturally competent interventions alongside familiar, usable media. For adolescents, technology is ubiquitous thus, the creation of a culturally tailored digital intervention has immense potential to improve cancer awareness and prevention for youth and their community. More research is needed to address many of the existing research gaps and develop a rich understanding of the unique experience of cancer among African immigrant families that can be used to inform intervention development. Through this viewpoint, we review the current state of cancer-related research among African immigrant families in the United States. In this paper, we acknowledge the current knowledge gaps and issues surrounding measurement and then discuss the factors relevant to designing an educational intervention targeted at African immigrants and the role of African immigrant youth.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e53956"},"PeriodicalIF":2.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10955401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxic Relationships Described by People With Breast Cancer on Reddit: Topic Modeling Study. Reddit 上乳腺癌患者描述的有毒关系:主题建模研究。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-02-23 DOI: 10.2196/48860
Cara Anne Davidson, Richard Booth, Kimberley Teresa Jackson, Tara Mantler

Background: Social support is essential to promoting optimal health outcomes for women with breast cancer. However, an estimated 12% of women with breast cancer simultaneously experience intimate partner violence (IPV; physical, psychological, or sexual abuse by an intimate partner). Women who experience IPV during breast cancer may lack traditional social support, and thus seek out alternative sources of support. Online community forums, such as Reddit, can provide accessible social connections within breast cancer-specific communities. However, it is largely unknown how women with breast cancer use Reddit to describe and seek support for experiences of IPV.

Objective: This study aims to explore how patients with breast cancer describe toxic relationships with their partners and immediate family members on Reddit.

Methods: This exploratory, cross-sectional, topic-modeling study analyzed textual data from 96 users in the r/breastcancer subreddit in February 2023. The meaning extraction method, inclusive of principal component analysis, was used to identify underlying components. Components were subjected to sentiment analysis and summative content analysis with emergent categorical development to articulate themes.

Results: Seven themes emerged related to toxic relationships: (1) contextualizing storytelling with lymph nodes, (2) toxic behavior and venting emotions, (3) abandonment and abuse following diagnosis, (4) toxic relationships and social-related fears, (5) inner strength and navigating breast cancer over time, (6) assessing social relationships and interactions, and (7) community advice and support. Toxic relationships were commonly characterized by isolation, abandonment, and emotional abuse, which had profound emotional consequences for patients. Reddit facilitated anonymous venting about toxic relationships that helped patients cope with intense feelings and stress. Exchanging advice and support about navigating toxic relationships during breast cancer were core functions of the r/breastcancer community.

Conclusions: Findings emphasized the value of Reddit as a source of social support for patients with breast cancer experiencing toxic relationships. Clinicians who understand that many patients with breast cancer experience toxic relationships and considerable psychological sequelae are better prepared to support their patients' holistic well-being. Further investigation of Reddit as a possible resource for advice, information, and support has the potential to help inform clinical practice and subsequently, patient health outcomes.

背景:社会支持对于促进乳腺癌女性患者获得最佳健康结果至关重要。然而,据估计有 12% 的乳腺癌妇女会同时遭受亲密伴侣暴力(IPV;亲密伴侣的身体、心理或性虐待)。患乳腺癌期间遭受亲密伴侣暴力的女性可能缺乏传统的社会支持,因此她们会寻求其他的支持来源。在线社区论坛(如 Reddit)可在乳腺癌特定社区内提供无障碍的社会联系。然而,患乳腺癌的妇女如何使用 Reddit 来描述 IPV 的经历并寻求支持,这在很大程度上还是个未知数:本研究旨在探讨乳腺癌患者如何在 Reddit 上描述与其伴侣和直系亲属之间的有毒关系:这项探索性、横断面、主题建模研究分析了 2023 年 2 月 r/breastcancer 子reddit 中 96 名用户的文本数据。研究采用意义提取法(包括主成分分析法)来识别潜在成分。对成分进行了情感分析和总结性内容分析,并对出现的主题进行了分类:出现了七个与有毒关系相关的主题:(1) 与淋巴结相关的故事背景;(2) 有毒行为和发泄情绪;(3) 诊断后的遗弃和虐待;(4) 有毒关系和与社会相关的恐惧;(5) 内在力量和长期应对乳腺癌;(6) 评估社会关系和互动;(7) 社区建议和支持。有毒关系通常以孤立、遗弃和情感虐待为特征,这对患者的情感造成了深远的影响。Reddit 为匿名宣泄有毒关系提供了便利,有助于患者应对强烈的情感和压力。r/breastcancer社区的核心功能是就乳腺癌期间如何处理有毒关系交流建议和提供支持:研究结果强调了 Reddit 作为社会支持来源的价值,它可以帮助乳腺癌患者体验有毒的人际关系。临床医生如果了解到许多乳腺癌患者都经历过有毒人际关系和严重的心理后遗症,就能更好地为患者的整体健康提供支持。将 Reddit 作为一种可能的建议、信息和支持资源进行进一步调查,有可能有助于指导临床实践,进而改善患者的健康状况。
{"title":"Toxic Relationships Described by People With Breast Cancer on Reddit: Topic Modeling Study.","authors":"Cara Anne Davidson, Richard Booth, Kimberley Teresa Jackson, Tara Mantler","doi":"10.2196/48860","DOIUrl":"10.2196/48860","url":null,"abstract":"<p><strong>Background: </strong>Social support is essential to promoting optimal health outcomes for women with breast cancer. However, an estimated 12% of women with breast cancer simultaneously experience intimate partner violence (IPV; physical, psychological, or sexual abuse by an intimate partner). Women who experience IPV during breast cancer may lack traditional social support, and thus seek out alternative sources of support. Online community forums, such as Reddit, can provide accessible social connections within breast cancer-specific communities. However, it is largely unknown how women with breast cancer use Reddit to describe and seek support for experiences of IPV.</p><p><strong>Objective: </strong>This study aims to explore how patients with breast cancer describe toxic relationships with their partners and immediate family members on Reddit.</p><p><strong>Methods: </strong>This exploratory, cross-sectional, topic-modeling study analyzed textual data from 96 users in the r/breastcancer subreddit in February 2023. The meaning extraction method, inclusive of principal component analysis, was used to identify underlying components. Components were subjected to sentiment analysis and summative content analysis with emergent categorical development to articulate themes.</p><p><strong>Results: </strong>Seven themes emerged related to toxic relationships: (1) contextualizing storytelling with lymph nodes, (2) toxic behavior and venting emotions, (3) abandonment and abuse following diagnosis, (4) toxic relationships and social-related fears, (5) inner strength and navigating breast cancer over time, (6) assessing social relationships and interactions, and (7) community advice and support. Toxic relationships were commonly characterized by isolation, abandonment, and emotional abuse, which had profound emotional consequences for patients. Reddit facilitated anonymous venting about toxic relationships that helped patients cope with intense feelings and stress. Exchanging advice and support about navigating toxic relationships during breast cancer were core functions of the r/breastcancer community.</p><p><strong>Conclusions: </strong>Findings emphasized the value of Reddit as a source of social support for patients with breast cancer experiencing toxic relationships. Clinicians who understand that many patients with breast cancer experience toxic relationships and considerable psychological sequelae are better prepared to support their patients' holistic well-being. Further investigation of Reddit as a possible resource for advice, information, and support has the potential to help inform clinical practice and subsequently, patient health outcomes.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e48860"},"PeriodicalIF":2.8,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Web-Based Scaffolds: The Feasibility of a Constructivist Approach to Oncology Fellow Learning. 基于网络的支架:肿瘤学研究员学习的建构主义方法的可行性。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-02-23 DOI: 10.2196/52501
Sam Brondfield, Matthew Schwede, Tyler P Johnson, Shagun Arora

In this 2-institution feasibility pilot, oncology fellows used and updated freely available web-based learning tools (scaffolds) in a constructivist fashion.

在这两个机构的可行性试点项目中,肿瘤学研究员以建构主义的方式使用并更新了免费提供的网络学习工具(支架)。
{"title":"Web-Based Scaffolds: The Feasibility of a Constructivist Approach to Oncology Fellow Learning.","authors":"Sam Brondfield, Matthew Schwede, Tyler P Johnson, Shagun Arora","doi":"10.2196/52501","DOIUrl":"10.2196/52501","url":null,"abstract":"<p><p>In this 2-institution feasibility pilot, oncology fellows used and updated freely available web-based learning tools (scaffolds) in a constructivist fashion.</p>","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e52501"},"PeriodicalIF":2.8,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10924254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Concordance Between Clinicians With Australian Guidelines for Bowel Cancer Prevention Using a Digital Application: Randomized Controlled Crossover Study. 利用数字应用程序提高临床医生与澳大利亚肠癌预防指南的一致性:随机对照交叉研究。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-02-22 DOI: 10.2196/46625
Tsai-Wing Ow, Olga Sukocheva, Peter Bampton, Guruparan Iyngkaran, Christopher K Rayner, Edmund Tse
<p><strong>Background: </strong>Australia's bowel cancer prevention guidelines, following a recent revision, are among the most complex in the world. Detailed decision tables outline screening or surveillance recommendations for 230 case scenarios alongside cessation recommendations for older patients. While these guidelines can help better allocate limited colonoscopy resources, their increasing complexity may limit their adoption and potential benefits. Therefore, tools to support clinicians in navigating these guidelines could be essential for national bowel cancer prevention efforts. Digital applications (DAs) represent a potentially inexpensive and scalable solution but are yet to be tested for this purpose.</p><p><strong>Objective: </strong>This study aims to assess whether a DA could increase clinician adherence to Australia's new colorectal cancer screening and surveillance guidelines and determine whether improved usability correlates with greater conformance to guidelines.</p><p><strong>Methods: </strong>As part of a randomized controlled crossover study, we created a clinical vignette quiz to evaluate the efficacy of a DA in comparison with the standard resource (SR) for making screening and surveillance decisions. Briefings were provided to study participants, which were tailored to their level of familiarity with the guidelines. We measured the adherence of clinicians according to their number of guideline-concordant responses to the scenarios in the quiz using either the DA or the SR. The maximum score was 18, with higher scores indicating improved adherence. We also tested the DA's usability using the System Usability Scale.</p><p><strong>Results: </strong>Of 117 participants, 80 were included in the final analysis. Using the SR, the adherence of participants was rated a median (IQR) score of 10 (7.75-13) out of 18. The participants' adherence improved by 40% (relative risk 1.4, P<.001) when using the DA, reaching a median (IQR) score of 14 (12-17) out of 18. The DA was rated highly for usability with a median (IQR) score of 90 (72.5-95) and ranked in the 96th percentile of systems. There was a moderate correlation between the usability of the DA and better adherence (r<sub>s</sub>=0.4; P<.001). No differences between the adherence of specialists and nonspecialists were found, either with the SR (10 vs 9; P=.47) or with the DA (13 vs 15; P=.24). There was no significant association between participants who were less adherent with the DA (n=17) and their age (P=.06), experience with decision support tools (P=.51), or academic involvement with a university (P=.39).</p><p><strong>Conclusions: </strong>DAs can significantly improve the adoption of complex Australian bowel cancer prevention guidelines. As screening and surveillance guidelines become increasingly complex and personalized, these tools will be crucial to help clinicians accurately determine the most appropriate recommendations for their patients. Additional research to und
背景:澳大利亚最近修订的肠癌预防指南是世界上最复杂的指南之一。详细的决策表概述了 230 种情况下的筛查或监测建议,以及针对老年患者的停药建议。虽然这些指南有助于更好地分配有限的结肠镜检查资源,但其日益增加的复杂性可能会限制其采用和潜在的益处。因此,支持临床医生掌握这些指南的工具对于国家肠癌预防工作至关重要。数字应用程序(DA)是一种潜在的廉价且可扩展的解决方案,但尚未为此进行测试:评估数字应用程序是否能提高临床医生对澳大利亚新的结直肠癌筛查和监测指南的依从性,并确定可用性的提高是否与更严格遵守指南相关:作为随机对照交叉研究的一部分,我们制作了一个临床小测验,以评估DA与标准资源(SR)相比在做出筛查和监测决定方面的功效。我们根据参与者对指南的熟悉程度为其提供了简介。我们根据临床医生使用 DA 或 SR 对测验中的情景做出与指南一致的回答的数量来衡量他们的依从性。最高分是 18 分,分数越高,说明遵守情况越好。我们还使用系统可用性量表(SUS)测试了 DA 的可用性:结果:在 117 名参与者中,有 80 人被纳入最终分析。使用 SR,参与者的依从性被评为中位数 10 分(满分 18 分,IQR 为 7.75 - 13)。参与者的依从性提高了 40%(RR 1.4,p 结论:DAs 可以显著提高依从性:DAs可以大大提高复杂的澳大利亚肠癌预防指南的采用率。随着筛查和监测指南变得越来越复杂和个性化,这些工具对于帮助临床医生准确确定最适合患者的建议至关重要。还需要开展更多的研究,以了解为什么有些医生在使用DAs时表现较差。进一步提高应用程序的可用性可能会进一步优化指南的一致性:
{"title":"Improving Concordance Between Clinicians With Australian Guidelines for Bowel Cancer Prevention Using a Digital Application: Randomized Controlled Crossover Study.","authors":"Tsai-Wing Ow, Olga Sukocheva, Peter Bampton, Guruparan Iyngkaran, Christopher K Rayner, Edmund Tse","doi":"10.2196/46625","DOIUrl":"10.2196/46625","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Australia's bowel cancer prevention guidelines, following a recent revision, are among the most complex in the world. Detailed decision tables outline screening or surveillance recommendations for 230 case scenarios alongside cessation recommendations for older patients. While these guidelines can help better allocate limited colonoscopy resources, their increasing complexity may limit their adoption and potential benefits. Therefore, tools to support clinicians in navigating these guidelines could be essential for national bowel cancer prevention efforts. Digital applications (DAs) represent a potentially inexpensive and scalable solution but are yet to be tested for this purpose.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to assess whether a DA could increase clinician adherence to Australia's new colorectal cancer screening and surveillance guidelines and determine whether improved usability correlates with greater conformance to guidelines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;As part of a randomized controlled crossover study, we created a clinical vignette quiz to evaluate the efficacy of a DA in comparison with the standard resource (SR) for making screening and surveillance decisions. Briefings were provided to study participants, which were tailored to their level of familiarity with the guidelines. We measured the adherence of clinicians according to their number of guideline-concordant responses to the scenarios in the quiz using either the DA or the SR. The maximum score was 18, with higher scores indicating improved adherence. We also tested the DA's usability using the System Usability Scale.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of 117 participants, 80 were included in the final analysis. Using the SR, the adherence of participants was rated a median (IQR) score of 10 (7.75-13) out of 18. The participants' adherence improved by 40% (relative risk 1.4, P&lt;.001) when using the DA, reaching a median (IQR) score of 14 (12-17) out of 18. The DA was rated highly for usability with a median (IQR) score of 90 (72.5-95) and ranked in the 96th percentile of systems. There was a moderate correlation between the usability of the DA and better adherence (r&lt;sub&gt;s&lt;/sub&gt;=0.4; P&lt;.001). No differences between the adherence of specialists and nonspecialists were found, either with the SR (10 vs 9; P=.47) or with the DA (13 vs 15; P=.24). There was no significant association between participants who were less adherent with the DA (n=17) and their age (P=.06), experience with decision support tools (P=.51), or academic involvement with a university (P=.39).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;DAs can significantly improve the adoption of complex Australian bowel cancer prevention guidelines. As screening and surveillance guidelines become increasingly complex and personalized, these tools will be crucial to help clinicians accurately determine the most appropriate recommendations for their patients. Additional research to und","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":" ","pages":"e46625"},"PeriodicalIF":2.8,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139492505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Health Psychosocial Intervention in Adult Patients With Cancer and Their Families: Systematic Review and Meta-Analysis. 成人癌症患者及其家属的数字健康社会心理干预:系统回顾与元分析》。
IF 2.8 Q2 ONCOLOGY Pub Date : 2024-02-05 DOI: 10.2196/46116
Yingzi Zhang, Marie Flannery, Zhihong Zhang, Meghan Underhill-Blazey, Melanie Bobry, Natalie Leblanc, Darcey Rodriguez, Chen Zhang
<p><strong>Background: </strong>Patients with cancer and their families often experience significant distress and deterioration in their quality of life. Psychosocial interventions were used to address patients' and families' psychosocial needs. Digital technology is increasingly being used to deliver psychosocial interventions to patients with cancer and their families.</p><p><strong>Objective: </strong>A systematic review and meta-analysis were conducted to review the characteristics and effectiveness of digital health interventions on psychosocial outcomes in adult patients with cancer and their family members.</p><p><strong>Methods: </strong>Databases (PubMed, Cochrane Library, Web of Science, Embase, CINAHL, PsycINFO, ProQuest Dissertations and Theses Global, and ClinicalTrials.gov) were searched for randomized controlled trials (RCTs) or quasi-experimental studies that tested the effects of a digital intervention on psychosocial outcomes. The Joanna Briggs Institute's critical appraisal checklists for RCTs and quasi-experimental studies were used to assess quality. Standardized mean differences (ie, Hedges g) were calculated to compare intervention effectiveness. Subgroup analysis was planned to examine the effect of delivery mode, duration of the intervention, type of control, and dosage on outcomes using a random-effects modeling approach.</p><p><strong>Results: </strong>A total of 65 studies involving 10,361 patients (mean 159, SD 166; range 9-803 patients per study) and 1045 caregivers or partners (mean 16, SD 54; range 9-244 caregivers or partners per study) were included in the systematic review. Of these, 32 studies were included in a meta-analysis of the effects of digital health interventions on quality of life, anxiety, depression, distress, and self-efficacy. Overall, the RCT studies' general quality was mixed (applicable scores: mean 0.61, SD 0.12; range 0.38-0.91). Quasi-experimental studies were generally of moderate to high quality (applicable scores: mean 0.75, SD 0.08; range 0.63-0.89). Psychoeducation and cognitive-behavioral strategies were commonly used. More than half (n=38, 59%) did not identify a conceptual or theoretical framework. Most interventions were delivered through the internet (n=40, 62%). The median number of intervention sessions was 6 (range 1-56). The frequency of the intervention was highly variable, with self-paced (n=26, 40%) being the most common. The median duration was 8 weeks. The meta-analysis results showed that digital psychosocial interventions were effective in improving patients' quality of life with a small effect size (Hedges g=0.05, 95% CI -0.01 to 0.10; I<sup>2</sup>=42.7%; P=.01). The interventions effectively reduced anxiety and depression symptoms in patients, as shown by moderate effect sizes on Hospital Anxiety and Depression Scale total scores (Hedges g=-0.72, 95% CI -1.89 to 0.46; I<sup>2</sup>=97.6%; P<.001).</p><p><strong>Conclusions: </strong>This study demonstrated the effecti
背景:癌症患者及其家属往往会感到非常痛苦,生活质量也会下降。社会心理干预被用来满足患者和家属的社会心理需求。数字技术正越来越多地被用于为癌症患者及其家属提供社会心理干预:通过系统综述和荟萃分析,研究数字健康干预对成年癌症患者及其家属的社会心理影响的特点和有效性:在PubMed、Cochrane Library、Web of Science、Embase、CINAHL、PsycINFO、ProQuest Dissertations and Theses Global和ClinicalTrials.gov等数据库中检索了测试数字干预对社会心理结果影响的随机对照试验(RCT)或准实验研究。乔安娜-布里格斯研究所(Joanna Briggs Institute)的随机对照试验和准实验研究批判性评估清单用于评估研究质量。计算标准化平均差(即赫奇斯 g)以比较干预效果。采用随机效应建模方法,计划进行分组分析,以研究实施模式、干预持续时间、对照类型和剂量对结果的影响:系统综述共纳入了 65 项研究,涉及 10,361 名患者(平均每项研究涉及 159 名患者,标准差为 166;范围为 9-803 名患者)和 1045 名护理人员或伴侣(平均每项研究涉及 16 名护理人员或伴侣,标准差为 54;范围为 9-244 名护理人员或伴侣)。其中,32 项研究被纳入了数字健康干预对生活质量、焦虑、抑郁、痛苦和自我效能影响的荟萃分析。总体而言,RCT 研究的总体质量参差不齐(适用分数:平均 0.61,标准差 0.12;范围 0.38-0.91)。准实验研究的质量一般为中上水平(适用分数:平均 0.75,标准差 0.08;范围 0.63-0.89)。心理教育和认知行为策略被普遍采用。半数以上(38 人,59%)没有确定概念或理论框架。大多数干预都是通过互联网进行的(人数=40,占 62%)。干预次数的中位数为 6 次(1-56 次不等)。干预的频率差异很大,最常见的是自定进度(26 人,占 40%)。持续时间的中位数为 8 周。荟萃分析结果表明,数字化心理干预能有效改善患者的生活质量,但影响范围较小(Hedges g=0.05, 95% CI -0.01 to 0.10; I2=42.7%; P=0.01)。干预措施有效减轻了患者的焦虑和抑郁症状,这体现在对医院焦虑抑郁量表总分的中等效应大小(Hedges g=-0.72, 95% CI -1.89 to 0.46; I2=97.6%; PConclusions:本研究证明了数字健康干预对患者生活质量、焦虑和抑郁的有效性。未来的研究需要对方法进行清晰的描述,以提高进行荟萃分析的能力。此外,本研究还提供了初步证据,支持在临床实践中整合现有的数字健康社会心理干预措施:ProCORD42020189698; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=189698.
{"title":"Digital Health Psychosocial Intervention in Adult Patients With Cancer and Their Families: Systematic Review and Meta-Analysis.","authors":"Yingzi Zhang, Marie Flannery, Zhihong Zhang, Meghan Underhill-Blazey, Melanie Bobry, Natalie Leblanc, Darcey Rodriguez, Chen Zhang","doi":"10.2196/46116","DOIUrl":"10.2196/46116","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Patients with cancer and their families often experience significant distress and deterioration in their quality of life. Psychosocial interventions were used to address patients' and families' psychosocial needs. Digital technology is increasingly being used to deliver psychosocial interventions to patients with cancer and their families.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;A systematic review and meta-analysis were conducted to review the characteristics and effectiveness of digital health interventions on psychosocial outcomes in adult patients with cancer and their family members.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Databases (PubMed, Cochrane Library, Web of Science, Embase, CINAHL, PsycINFO, ProQuest Dissertations and Theses Global, and ClinicalTrials.gov) were searched for randomized controlled trials (RCTs) or quasi-experimental studies that tested the effects of a digital intervention on psychosocial outcomes. The Joanna Briggs Institute's critical appraisal checklists for RCTs and quasi-experimental studies were used to assess quality. Standardized mean differences (ie, Hedges g) were calculated to compare intervention effectiveness. Subgroup analysis was planned to examine the effect of delivery mode, duration of the intervention, type of control, and dosage on outcomes using a random-effects modeling approach.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 65 studies involving 10,361 patients (mean 159, SD 166; range 9-803 patients per study) and 1045 caregivers or partners (mean 16, SD 54; range 9-244 caregivers or partners per study) were included in the systematic review. Of these, 32 studies were included in a meta-analysis of the effects of digital health interventions on quality of life, anxiety, depression, distress, and self-efficacy. Overall, the RCT studies' general quality was mixed (applicable scores: mean 0.61, SD 0.12; range 0.38-0.91). Quasi-experimental studies were generally of moderate to high quality (applicable scores: mean 0.75, SD 0.08; range 0.63-0.89). Psychoeducation and cognitive-behavioral strategies were commonly used. More than half (n=38, 59%) did not identify a conceptual or theoretical framework. Most interventions were delivered through the internet (n=40, 62%). The median number of intervention sessions was 6 (range 1-56). The frequency of the intervention was highly variable, with self-paced (n=26, 40%) being the most common. The median duration was 8 weeks. The meta-analysis results showed that digital psychosocial interventions were effective in improving patients' quality of life with a small effect size (Hedges g=0.05, 95% CI -0.01 to 0.10; I&lt;sup&gt;2&lt;/sup&gt;=42.7%; P=.01). The interventions effectively reduced anxiety and depression symptoms in patients, as shown by moderate effect sizes on Hospital Anxiety and Depression Scale total scores (Hedges g=-0.72, 95% CI -1.89 to 0.46; I&lt;sup&gt;2&lt;/sup&gt;=97.6%; P&lt;.001).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study demonstrated the effecti","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e46116"},"PeriodicalIF":2.8,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10877499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Quality, Privacy, and Security of Breast Cancer Apps for Arabic Speakers: Systematic Search and Review of Smartphone Apps. 评估阿拉伯语用户使用的乳腺癌应用程序的质量、隐私和安全性:智能手机应用程序的系统搜索和审查。
IF 3.3 Q2 ONCOLOGY Pub Date : 2024-01-16 DOI: 10.2196/48428
Dari Alhuwail, Aisha Alhouti, Latifah Alsarhan
<p><strong>Background: </strong>Breast cancer is a widespread disease, and its incidence is rapidly increasing in the Middle East and North Africa region. With the increasing availability of smartphone apps for various health purposes, breast cancer apps have emerged as tools for raising awareness, providing support, and empowering women affected by this disease. These apps offer many features, including information on breast cancer risk factors, self-examination guides, appointment reminders, and community support groups or hotlines. Using apps raises the risk of privacy and security issues, and we hope that examining these features of the apps will contribute to the understanding of how technology can be used to improve these apps and provide insights for future development and improvement of breast cancer apps.</p><p><strong>Objective: </strong>This study aims to critically review the quality, privacy, and security of breast cancer apps available to Arabic speakers.</p><p><strong>Methods: </strong>Similar to several recent studies, we used a systematic search for apps available in Google Play and Apple App stores using both the web interface and the built-in native stores installed on smartphones. The search was conducted in mid-December 2022 in Arabic using the following keywords: سرطان الثدي - فحص سرطان الثدي - علاج سرطان الثدي - مرض سرطان الثدي - أعراض سرطان الثدي - فحص الثدي (breast cancer, breast cancer treatment, breast cancer disease, breast cancer symptoms, breast cancer screening, and breast test). These preidentified search terms are based on earlier work concerning the top searched breast cancer topics by Arabic speakers through Google's search engine. We excluded apps that did not have an Arabic interface, were developed for non-Arabic speakers, were paid, needed a subscription, or were directed toward health care workers. The Mobile App Rating Scale was used to evaluate the quality of the apps concerning their engagement, functionality, aesthetics, and information. A risk score was calculated for the apps to determine their security risk factors.</p><p><strong>Results: </strong>Only 9 apps were included, with most (6/9, 67%) being supported by advertisements and categorized as informational. Overall, the apps had low numbers of downloads (>10 to >1000). The majority of the included apps (8/9, 89%) requested dangerous access permissions, including access to storage, media files, and the camera. The average security score of the included apps was 3.22, while only 2 apps provided information about data security and privacy. The included apps achieved an overall average quality score of 3.27, with individual dimension scores of 4.75 for functionality, 3.04 for information, 3.00 for aesthetics, and 2.32 for engagement.</p><p><strong>Conclusions: </strong>The limited availability of breast cancer apps available to Arabic speakers should be a call to action and prompt health care organizations and developers to join forces and collaborat
背景:乳腺癌是一种广泛传播的疾病,其发病率在中东和北非地区迅速上升。随着用于各种健康目的的智能手机应用程序越来越多,乳腺癌应用程序已成为提高人们对该疾病的认识、提供支持和增强受该疾病影响的妇女能力的工具。这些应用程序提供了许多功能,包括有关乳腺癌风险因素的信息、自我检查指南、预约提醒以及社区支持小组或热线。使用应用程序会带来隐私和安全问题的风险,我们希望通过对应用程序这些功能的研究,有助于了解如何利用技术来改进这些应用程序,并为今后开发和改进乳腺癌应用程序提供启示:本研究旨在严格审查阿拉伯语用户可使用的乳腺癌应用程序的质量、隐私和安全性:与最近的几项研究类似,我们使用网络界面和智能手机上安装的内置本地商店对 Google Play 和 Apple App 商店中的应用程序进行了系统搜索。搜索于 2022 年 12 月中旬进行,使用的阿拉伯语关键词如下:سرطان الثدي - فحص سرطان الثدي - علاج سرطان الثدي - مرض سرطان الثدي - أعراض سرطان الثدي - فحص الثدي(乳腺癌、乳腺癌治疗、乳腺癌疾病、乳腺癌症状、乳腺癌筛查和乳腺测试)。这些预先确定的搜索词是基于早先的工作,即阿拉伯语使用者通过谷歌搜索引擎搜索乳腺癌主题的热门话题。我们排除了没有阿拉伯语界面、为非阿拉伯语使用者开发、付费、需要订阅或面向医护人员的应用程序。我们使用了移动应用程序评分表来评估应用程序在参与性、功能性、美观性和信息方面的质量。此外,还计算了应用程序的风险分数,以确定其安全风险因素:只有 9 款应用程序被纳入其中,其中大部分(6/9,67%)有广告支持,并被归类为信息类。总体而言,这些应用程序的下载量较低(>10 到 >1000)。大部分被收录的应用程序(8/9,89%)都要求获得危险的访问权限,包括访问存储空间、媒体文件和摄像头。收录应用程序的平均安全得分为 3.22 分,只有 2 款应用程序提供了有关数据安全和隐私的信息。收录应用的总体平均质量得分为 3.27 分,单个维度的得分分别为:功能性 4.75 分、信息性 3.04 分、美观性 3.00 分和参与性 2.32 分:阿拉伯语用户可使用的乳腺癌应用程序数量有限,这应该成为一个行动号召,促使医疗机构和开发人员联合起来,共同开发信息丰富、可用、功能强大、吸引人和安全的应用程序。
{"title":"Assessing the Quality, Privacy, and Security of Breast Cancer Apps for Arabic Speakers: Systematic Search and Review of Smartphone Apps.","authors":"Dari Alhuwail, Aisha Alhouti, Latifah Alsarhan","doi":"10.2196/48428","DOIUrl":"10.2196/48428","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Breast cancer is a widespread disease, and its incidence is rapidly increasing in the Middle East and North Africa region. With the increasing availability of smartphone apps for various health purposes, breast cancer apps have emerged as tools for raising awareness, providing support, and empowering women affected by this disease. These apps offer many features, including information on breast cancer risk factors, self-examination guides, appointment reminders, and community support groups or hotlines. Using apps raises the risk of privacy and security issues, and we hope that examining these features of the apps will contribute to the understanding of how technology can be used to improve these apps and provide insights for future development and improvement of breast cancer apps.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to critically review the quality, privacy, and security of breast cancer apps available to Arabic speakers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Similar to several recent studies, we used a systematic search for apps available in Google Play and Apple App stores using both the web interface and the built-in native stores installed on smartphones. The search was conducted in mid-December 2022 in Arabic using the following keywords: سرطان الثدي - فحص سرطان الثدي - علاج سرطان الثدي - مرض سرطان الثدي - أعراض سرطان الثدي - فحص الثدي (breast cancer, breast cancer treatment, breast cancer disease, breast cancer symptoms, breast cancer screening, and breast test). These preidentified search terms are based on earlier work concerning the top searched breast cancer topics by Arabic speakers through Google's search engine. We excluded apps that did not have an Arabic interface, were developed for non-Arabic speakers, were paid, needed a subscription, or were directed toward health care workers. The Mobile App Rating Scale was used to evaluate the quality of the apps concerning their engagement, functionality, aesthetics, and information. A risk score was calculated for the apps to determine their security risk factors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Only 9 apps were included, with most (6/9, 67%) being supported by advertisements and categorized as informational. Overall, the apps had low numbers of downloads (&gt;10 to &gt;1000). The majority of the included apps (8/9, 89%) requested dangerous access permissions, including access to storage, media files, and the camera. The average security score of the included apps was 3.22, while only 2 apps provided information about data security and privacy. The included apps achieved an overall average quality score of 3.27, with individual dimension scores of 4.75 for functionality, 3.04 for information, 3.00 for aesthetics, and 2.32 for engagement.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The limited availability of breast cancer apps available to Arabic speakers should be a call to action and prompt health care organizations and developers to join forces and collaborat","PeriodicalId":45538,"journal":{"name":"JMIR Cancer","volume":"10 ","pages":"e48428"},"PeriodicalIF":3.3,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139472168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1